Option Care Health initiated with an Outperform at JMP Securities

JMP Securities initiated coverage of Option Care Health with an Outperform rating and $36 price target. Option Care is the largest provider of home infusion services in the country and JMP is constructive on the opportunity for the company to continue to gain share, given its nationwide footprint, broad menu of therapies, and a difficult-to-replicate commercial infrastructure, the analyst tells investors in a research note. The firm sees strong secular drivers and solid growth for the home infusion market.